Agilon Health Inc [AGL] stock prices are up 0.44% to $2.29 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AGL shares have gain 4.57% over the last week, with a monthly amount drifted -22.90%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on April 25, 2025, when Citigroup upgraded its rating to a Buy but kept the price target unchanged to $5 for it. Previously, Bernstein upgraded its rating to Outperform on April 08, 2025, and kept the price target unchanged to $8.50. On January 10, 2025, upgrade upgraded it’s rating to Neutral and revised its price target to $2.25 on the stock. Needham started tracking the stock assigning a Hold rating. Macquarie initiated its recommendation with a Neutral. Bernstein started tracking with a Mkt Perform rating for this stock on December 11, 2024, and assigned it a price target of $2.50. In a note dated November 11, 2024, JMP Securities downgraded an Mkt Perform rating on this stock.
The stock price of Agilon Health Inc [AGL] has been fluctuating between $1.50 and $7.73 over the past year. Currently, Wall Street analysts expect the stock to reach $4.4 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $2.29 at the most recent close of the market. An investor can expect a potential return of 92.14% based on the average AGL price forecast.
Analyzing the AGL fundamentals
The Agilon Health Inc [NYSE:AGL] reported sales of 5.99B for trailing twelve months, representing a drop of -4.46%. Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.44 and Total Capital is -0.55. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.21 points at the first support level, and at 2.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.41, and for the 2nd resistance point, it is at 2.52.
Ratios To Look Out For
It’s worth pointing out that Agilon Health Inc [NYSE:AGL]’s Current Ratio is 1.20. Also, the Quick Ratio is 1.20, while the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 0.16, the price to book ratio is 1.89.
Transactions by insiders
Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.
